Beyhan Durak Aras
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Beyhan Durak Aras has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Sevilhan Artan
Department of Medical Genetics, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkiye
7 shared publications - Ebru Erzurumluoglu Gokalp
Department of Medical Genetics, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkiye
6 shared publications - Gülçin Günden
Eskişehir Osmangazi Üniversitesi
6 shared publications - Sevgi Isik
Eskişehir Osmangazi Üniversitesi
6 shared publications Sevilhan Artan
Department of Medical Genetics, Faculty of Medicine, University of Eskisehir Osmangazi, Eskisehir, Turkey
5 shared publications- Hülya Özen
Department of Medical Informatics, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye
3 shared publications
Latest Publications
- Open Access
- 12 February 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (1) , 377-385
Nonclassical Philadelphia-positive FISH signal patterns in CML and seven cases with variant Philadelphia
Background/aim: Chronic myeloid leukemia (CML) is characterized by the Philadelphia chromosome (Ph), which occurs as a result of t(9;22). In 5%–10% of CML cases, variant t(9;22)s are observed. Additionally, while t(9;22) is formed, deletions can be observed in chromosomes 9 and 22. These deletions are observed more frequently in variant t(9;22). There is conflicting information in the literature about the prognostic effects of variant t(9;22) and deletions of 9q and 22q. There is also limited information about the frequency and breakpoints of other chromosomes involved in the variant t(9;22). Signal patterns other than the classical signal pattern of FISH analysis indicate deletions and variant translocations. In this study, we aimed to investigate the clinical significance of nonclassical FISH signal patterns and to determine the frequency of variant translocations. Materials and methods: Bone marrow samples from 231 newly diagnosed CML patients were analyzed by conventional cytogenetics and FISH. Results: As a result of FISH analysis, nonclassical FISH signal patterns were detected in 49/231 cases, and variant t(9;22) was detected in seven cases by conventional cytogenetics. It was determined that chromosomes 1, 3, 5, 7, 8, and 21 were involved in variant t(9;22). When cases with classical and nonclassical signal patterns were compared in terms of 6th- and 12th-month treatment responses, survival times, and treatment changes, it was found that cases with classical signal patterns had significantly higher treatment responses at the 6th month (p < 0.001). Conclusion: Because variant translocations are extremely rare and involve many different chromosomal breaks, a large number of cases are needed to clearly understand their prognostic implications. Due to the limitations of conventional cytogenetic analyses, it should be considered in patient follow-up that nonclassical FISH signal patterns indicating deletions and/or variant translocations may cause a delay in obtaining a complete cytogenetic response at the 6th month.
- 12 February 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (1) , 377-385
Open AccessNonclassical Philadelphia-positive FISH signal patterns in CML and seven cases with variant Philadelphia
Background/aim: Chronic myeloid leukemia (CML) is characterized by the Philadelphia chromosome (Ph), which occurs as a result of t(9;22). In 5%–10% of CML cases, variant t(9;22)s are observed. Additionally, while t(9;22) is formed, deletions can be observed in chromosomes 9 and 22. These deletions are observed more frequently in variant t(9;22). There is conflicting information in the literature about the prognostic effects of variant t(9;22) and deletions of 9q and 22q. There is also limited information about the frequency and breakpoints of other chromosomes involved in the variant t(9;22). Signal patterns other than the classical signal pattern of FISH analysis indicate deletions and variant translocations. In this study, we aimed to investigate the clinical significance of nonclassical FISH signal patterns and to determine the frequency of variant translocations. Materials and methods: Bone marrow samples from 231 newly diagnosed CML patients were analyzed by conventional cytogenetics and FISH. Results: As a result of FISH analysis, nonclassical FISH signal patterns were detected in 49/231 cases, and variant t(9;22) was detected in seven cases by conventional cytogenetics. It was determined that chromosomes 1, 3, 5, 7, 8, and 21 were involved in variant t(9;22). When cases with classical and nonclassical signal patterns were compared in terms of 6th- and 12th-month treatment responses, survival times, and treatment changes, it was found that cases with classical signal patterns had significantly higher treatment responses at the 6th month (p < 0.001). Conclusion: Because variant translocations are extremely rare and involve many different chromosomal breaks, a large number of cases are needed to clearly understand their prognostic implications. Due to the limitations of conventional cytogenetic analyses, it should be considered in patient follow-up that nonclassical FISH signal patterns indicating deletions and/or variant translocations may cause a delay in obtaining a complete cytogenetic response at the 6th month.
- 15 December 2025
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (1) , 7-12
Evaluation of Stromal Fibrosis in Triple-Negative Breast Carcinomas
Triple-negative breast carcinoma is a subtype of breast cancer characterized by the absence of estrogen and progesterone hormone receptors, as well as HER2 protein expression. It typically exhibits an aggressive clinical course and resistance to treatment. Due to its limited therapeutic options and poor prognostic features, this subgroup holds clinical significance. In recent years, the tumor microenvironment has emerged as a critical area of cancer research, with stromal components gaining attention for their role in tumor progression and treatment resistance. This study retrospectively evaluated the relationship between the size of fibrotic foci observed in the tumor stroma and histopathological prognostic parameters in triple-negative breast carcinoma cases. A total of 26 cases operated between 2018 and 2025, confirmed to be negative for hormone receptors and HER2 protein, were included in the study. Hematoxylin-eosin and Masson's trichrome-stained slides were examined. The largest stromal fibrotic focus was measured and statistically compared with tumor size, tumor and nuclear grade, Ki-67 proliferation index, lymphovascular invasion, axillary lymph node status, presence of tumor-infiltrating lymphocytes, ductal carcinoma in situ, and necrosis. According to the data obtained, no statistically significant correlation was found between stromal fibrosis size and the prognostic variables examined. However, significant associations were observed between some individual parameters. The findings suggest that further large-scale, multicenter studies are necessary to more clearly determine the prognostic value of stromal fibrosis in triple-negative breast carcinoma
- 15 December 2025
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (1) , 7-12
Evaluation of Stromal Fibrosis in Triple-Negative Breast Carcinomas
Triple-negative breast carcinoma is a subtype of breast cancer characterized by the absence of estrogen and progesterone hormone receptors, as well as HER2 protein expression. It typically exhibits an aggressive clinical course and resistance to treatment. Due to its limited therapeutic options and poor prognostic features, this subgroup holds clinical significance. In recent years, the tumor microenvironment has emerged as a critical area of cancer research, with stromal components gaining attention for their role in tumor progression and treatment resistance. This study retrospectively evaluated the relationship between the size of fibrotic foci observed in the tumor stroma and histopathological prognostic parameters in triple-negative breast carcinoma cases. A total of 26 cases operated between 2018 and 2025, confirmed to be negative for hormone receptors and HER2 protein, were included in the study. Hematoxylin-eosin and Masson's trichrome-stained slides were examined. The largest stromal fibrotic focus was measured and statistically compared with tumor size, tumor and nuclear grade, Ki-67 proliferation index, lymphovascular invasion, axillary lymph node status, presence of tumor-infiltrating lymphocytes, ductal carcinoma in situ, and necrosis. According to the data obtained, no statistically significant correlation was found between stromal fibrosis size and the prognostic variables examined. However, significant associations were observed between some individual parameters. The findings suggest that further large-scale, multicenter studies are necessary to more clearly determine the prognostic value of stromal fibrosis in triple-negative breast carcinoma
- 15 December 2025
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (1) , 133-136
Multiple Myeloma’da Sitogenetik Ve FISH Analizlerinin Rolü: 1279 Olguluk Deneyime Dayalı Yöntemsel Bir Değerlendirme
Multiple myeloma klinik açıdan heterojen bir hematolojik hastalık olup, bu heterojenitede genetik anomalilerin çeşitliliği rol oynamaktadır. MM’da prognostik önemi olduğu bilinen kromozom anomalilerinin tespitinde FISH yöntemi altın standarttır ve plazma hücreleri ayrıştırılarak bu testin uygunlanması önerilmektedir. Tüm kromozomların analizine imkan veren KS testinin ise bu hasta grubunda başarı oranı %10 olarak bilinmektedir. Plazma hücrelerinin ayrıştırılması olanağına her laboratuvar sahip olmadığı için, çalışmamızda bu uygulama yapılmadan FISH ve KS testlerinin çalışıldığı 1279 olguya ait verileri değerlendirmeyi ve bu testlerin etkinliklerini araştırmayı amaçladık. Çalışma kapsamında olguların tanı ve takiplerinde eş zamanlı çalışılan toplam 1794 FISH ve KS test sonuçlarını değerlendirdik. FISH ve/veya KS ile anomali saptanan olgu sayısı 312 (%24,39)’dir. Sadece FISH analizleri anomali saptama oranı ise %13,39’dur. Kromozom 1 anomalileri ve IGH yeniden düzenlenmeleri en sık saptanan anomaliler arasındadır. 1794 KS testinin başarı oranı ise %63.82’dir. Ayrıca FISH analizleri normal sonuçlanan ancak KS ile anomali saptanan analiz sayısı 111’dir. Multiple myelom FISH paneli dışında bu 111 analizde en sık tekrarlayan anomaliler Y kaybından sonra 6q delesyonlarıdır. Plazma hücrelerini hedef almadan yapılan direkt FISH testlerinde anomali saptama oranımız literatürdeki veriler ile uyumludur. Çalışmamız sonucunda yapılan KS test başarı oranı ise literatürde belirtilen oranın oldukça üstündedir. Ayrıca FISH testi ile tespit edilemeyen kromozom anomalilerin saptanmasında KS testinin rolü bir kez daha ortaya koyulmuştur. Sonuç olarak; elde edilen veriler MM progresyonunda etkili ve yeni tedavi hedefi olabilecek anomalilerin tanımlanması için FISH ve KS testlerinin eş zamanlı yürütülmesi gerekliliğine ve plazma hücresi ayrıştırma imkanı bulamayan merkezlerin bu testleri yapmaktan uzak durmamaları gerekliliğine dikkat çekecek özelliktedir.
- 15 December 2025
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (1) , 133-136
Multiple Myeloma’da Sitogenetik Ve FISH Analizlerinin Rolü: 1279 Olguluk Deneyime Dayalı Yöntemsel Bir Değerlendirme
Multiple myeloma klinik açıdan heterojen bir hematolojik hastalık olup, bu heterojenitede genetik anomalilerin çeşitliliği rol oynamaktadır. MM’da prognostik önemi olduğu bilinen kromozom anomalilerinin tespitinde FISH yöntemi altın standarttır ve plazma hücreleri ayrıştırılarak bu testin uygunlanması önerilmektedir. Tüm kromozomların analizine imkan veren KS testinin ise bu hasta grubunda başarı oranı %10 olarak bilinmektedir. Plazma hücrelerinin ayrıştırılması olanağına her laboratuvar sahip olmadığı için, çalışmamızda bu uygulama yapılmadan FISH ve KS testlerinin çalışıldığı 1279 olguya ait verileri değerlendirmeyi ve bu testlerin etkinliklerini araştırmayı amaçladık. Çalışma kapsamında olguların tanı ve takiplerinde eş zamanlı çalışılan toplam 1794 FISH ve KS test sonuçlarını değerlendirdik. FISH ve/veya KS ile anomali saptanan olgu sayısı 312 (%24,39)’dir. Sadece FISH analizleri anomali saptama oranı ise %13,39’dur. Kromozom 1 anomalileri ve IGH yeniden düzenlenmeleri en sık saptanan anomaliler arasındadır. 1794 KS testinin başarı oranı ise %63.82’dir. Ayrıca FISH analizleri normal sonuçlanan ancak KS ile anomali saptanan analiz sayısı 111’dir. Multiple myelom FISH paneli dışında bu 111 analizde en sık tekrarlayan anomaliler Y kaybından sonra 6q delesyonlarıdır. Plazma hücrelerini hedef almadan yapılan direkt FISH testlerinde anomali saptama oranımız literatürdeki veriler ile uyumludur. Çalışmamız sonucunda yapılan KS test başarı oranı ise literatürde belirtilen oranın oldukça üstündedir. Ayrıca FISH testi ile tespit edilemeyen kromozom anomalilerin saptanmasında KS testinin rolü bir kez daha ortaya koyulmuştur. Sonuç olarak; elde edilen veriler MM progresyonunda etkili ve yeni tedavi hedefi olabilecek anomalilerin tanımlanması için FISH ve KS testlerinin eş zamanlı yürütülmesi gerekliliğine ve plazma hücresi ayrıştırma imkanı bulamayan merkezlerin bu testleri yapmaktan uzak durmamaları gerekliliğine dikkat çekecek özelliktedir.
- Open Access
- 14 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Investigating the dual role of mitochondrial and nuclear genome variants in pediatric cardiomyopathies
Mitochondrial defects can lead to cardiomyopathies, which can be particularly severe in children. However, many cases of pediatric cardiomyopathy have no known etiology. To address this, we sought to explore if mitochondrial genome defects might be a contributor, as this could offer insights into disease mechanisms and guide targeted interventions. We first sequenced cardiomyopathy-related genes in twenty-seven pediatric patients diagnosed with primary non-syndromic cardiomyopathy and performed whole mtDNA sequencing in both patients and thirty-one healthy controls. The initial sequencing identified pathogenic variants in seven patients but subsequent mtDNA sequencing revealed additional insights. Specifically, a variant in FOXRED1, encoding FAD-dependent oxidoreductase domain-containing protein-1 which functions in mitochondrial complex I stability, and another variant in cytochrome c oxidase-I, MT-CO1, crucial for aerobic metabolism, were identified in two siblings with hypertrophic cardiomyopathy. In another case with hypertrophic cardiomyopathy, a variant in cytochrome b, MT-CYB, is likely a key factor in the abnormal contraction of cardiac muscle contraction. Furthermore, a novel 12 S rRNA variant was found in a patient with left ventricular non-compaction, and this offers a promising explanation for the pathogenesis, given the gene’s high expression in the left ventricle. Taken together, mtDNA variants act synergistically with others, potentially disrupting myocardial bioenergetics.
- 14 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessInvestigating the dual role of mitochondrial and nuclear genome variants in pediatric cardiomyopathies
Mitochondrial defects can lead to cardiomyopathies, which can be particularly severe in children. However, many cases of pediatric cardiomyopathy have no known etiology. To address this, we sought to explore if mitochondrial genome defects might be a contributor, as this could offer insights into disease mechanisms and guide targeted interventions. We first sequenced cardiomyopathy-related genes in twenty-seven pediatric patients diagnosed with primary non-syndromic cardiomyopathy and performed whole mtDNA sequencing in both patients and thirty-one healthy controls. The initial sequencing identified pathogenic variants in seven patients but subsequent mtDNA sequencing revealed additional insights. Specifically, a variant in FOXRED1, encoding FAD-dependent oxidoreductase domain-containing protein-1 which functions in mitochondrial complex I stability, and another variant in cytochrome c oxidase-I, MT-CO1, crucial for aerobic metabolism, were identified in two siblings with hypertrophic cardiomyopathy. In another case with hypertrophic cardiomyopathy, a variant in cytochrome b, MT-CYB, is likely a key factor in the abnormal contraction of cardiac muscle contraction. Furthermore, a novel 12 S rRNA variant was found in a patient with left ventricular non-compaction, and this offers a promising explanation for the pathogenesis, given the gene’s high expression in the left ventricle. Taken together, mtDNA variants act synergistically with others, potentially disrupting myocardial bioenergetics.
- Open Access
Uncovering the Dual Role of Mitochondrial and Nuclear DNA Variants in Pediatric Cardiomyopathies
Myocardial defects, originating from disruptions in genes affecting mitochondrial proteins interacting with others, have received limited research attention. In our study involving 27 pediatric cardiomyopathy patients, we explored mitochondrial and nuclear genes for four main cardiomyopathy subtypes. Sequencing cardiomyopathy-associated genes in patients was followed by whole mtDNA sequencing in these individuals, with 31 healthy pediatric controls for the latter part. Our findings uncovered significant pathogenic variants: MYH7 variants in three hypertrophic cardiomyopathy cases, a notable TNNC1 variant inherited interestingly in an autosomal recessive manner in two related restrictive cardiomyopathy patients, and a pathogenic TRDN variant in a left-ventricular non-compaction patient. Both a variant in FOXRED1, functioning in mitochondrial complex I stability, and a MT-CO1 variant were detected in two siblings, influencing early onset together. Additionally, a novel MT-RNR1 variant (m.684T>C) in one case might explain the phenotype. Our study highlights how both mtDNA and nDNA variants could have interconnected roles in understanding cardiomyopathy genetics. This study emphasizes that the functional studies are needed to recognize this dual relationship within bioenergetic pathways in cardiac muscle.
Open AccessUncovering the Dual Role of Mitochondrial and Nuclear DNA Variants in Pediatric Cardiomyopathies
Myocardial defects, originating from disruptions in genes affecting mitochondrial proteins interacting with others, have received limited research attention. In our study involving 27 pediatric cardiomyopathy patients, we explored mitochondrial and nuclear genes for four main cardiomyopathy subtypes. Sequencing cardiomyopathy-associated genes in patients was followed by whole mtDNA sequencing in these individuals, with 31 healthy pediatric controls for the latter part. Our findings uncovered significant pathogenic variants: MYH7 variants in three hypertrophic cardiomyopathy cases, a notable TNNC1 variant inherited interestingly in an autosomal recessive manner in two related restrictive cardiomyopathy patients, and a pathogenic TRDN variant in a left-ventricular non-compaction patient. Both a variant in FOXRED1, functioning in mitochondrial complex I stability, and a MT-CO1 variant were detected in two siblings, influencing early onset together. Additionally, a novel MT-RNR1 variant (m.684T>C) in one case might explain the phenotype. Our study highlights how both mtDNA and nDNA variants could have interconnected roles in understanding cardiomyopathy genetics. This study emphasizes that the functional studies are needed to recognize this dual relationship within bioenergetic pathways in cardiac muscle.
- Open Access
- 15 December 2023
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 34 (12) , 1240-1248
Genetic Investigations in Turkish Idiopathic Pancreatitis Patients Show Unique Characteristics
Background/Aims: Pancreatitis is one of the leading causes of digestive system-related hospital admissions, and it has a genetic background in a considerable portion of the patients. In this study, we aimed to investigate the genetic risk factors of idiopathic pancreatitis in Turkish patients and the contribution of copy number variations to the pathogenesis. Materials and Methods: Idiopathic pancreatitis is defined as failure to detect risk factors despite comprehensive clinical assessments. Next-generation sequencing and multiple ligand-dependent probe amplification of PRSS1, SPINK1, CTRC, and CFTR were performed. For further genotype–phenotype correlations, patients were also questioned for the age of onset, family history, and pancreatic divisum. Results: A total of 68 idiopathic pancreatitis cases were enrolled. Variants with potential clinical significance of PRSS1 were identified in 13.4%, SPINK1 in 6.3%, CTRC in 4.7%, and CFTR in 26.5% of the patients. No copy number variants were seen in any of these genes. At least 7.4% of the participants had complex genetic etiology involving 2 genes. Conclusions: At least 42.6% of the participants had a potential genetic risk factor. Five novel genetic variants were identified, and distinctive genetic risk factors of Turkish population were shown. The results showed that genetic etiology was frequent in pancreatitis and it was even more prominent in patients with early-onset disease. Considering that genetic risk factors may be informative for decisionmaking in the treatment options in addition to providing extensive prognostic value and familial genetic consultation; clinicians need to be more eager to offer genetic tests to pancreatitis patients.
- 15 December 2023
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 34 (12) , 1240-1248
Open AccessGenetic Investigations in Turkish Idiopathic Pancreatitis Patients Show Unique Characteristics
Background/Aims: Pancreatitis is one of the leading causes of digestive system-related hospital admissions, and it has a genetic background in a considerable portion of the patients. In this study, we aimed to investigate the genetic risk factors of idiopathic pancreatitis in Turkish patients and the contribution of copy number variations to the pathogenesis. Materials and Methods: Idiopathic pancreatitis is defined as failure to detect risk factors despite comprehensive clinical assessments. Next-generation sequencing and multiple ligand-dependent probe amplification of PRSS1, SPINK1, CTRC, and CFTR were performed. For further genotype–phenotype correlations, patients were also questioned for the age of onset, family history, and pancreatic divisum. Results: A total of 68 idiopathic pancreatitis cases were enrolled. Variants with potential clinical significance of PRSS1 were identified in 13.4%, SPINK1 in 6.3%, CTRC in 4.7%, and CFTR in 26.5% of the patients. No copy number variants were seen in any of these genes. At least 7.4% of the participants had complex genetic etiology involving 2 genes. Conclusions: At least 42.6% of the participants had a potential genetic risk factor. Five novel genetic variants were identified, and distinctive genetic risk factors of Turkish population were shown. The results showed that genetic etiology was frequent in pancreatitis and it was even more prominent in patients with early-onset disease. Considering that genetic risk factors may be informative for decisionmaking in the treatment options in addition to providing extensive prognostic value and familial genetic consultation; clinicians need to be more eager to offer genetic tests to pancreatitis patients.
- Open Access
- 8 December 2023
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (1) , 104-109
KLL Olgularında NOTCH1 Gen Amplifikasyonu
Kronik lenfositik lösemi (KLL) ileri yaş hastalarda en sık gözlenen lösemi türü olup, hem klinik hem de genetik açıdan oldukça heterojen bir hastalıktır. Kronik lenfositik lösemi de tekrarlayan kromozom anomalilerinin prognostik önemleri uzun yıllardır bilinmekte olup, gen mutasyonlarının da klinik önemleri açığa kavuşmaya başlamıştır. NOTCH1 gen mutasyonları KLL’de en sık mutasyon gözlenen gen olup, tedavi direnci ve Richter Sendromuna dönüşüm ile ilişkilendirilmektedir. Son yıllarda yapılan çalışmalarda NOTCH1 gen amplifikasyonları çeşitli kanser tiplerinde raporlanmıştır. Bizim daha önce izole delesyon 13q saptanan KLL vakaları ile yaptığımız bir çalışmada NOTCH1 gen dizisini içeren kopya sayısı artışları mikroarray yöntemi ile saptanmıştır ancak klinik bulgular ile ilişkilendirilmemiştir. Biz de bu çalışmamızda çeşitli kromozomal anomalilere sahip ve daha fazla KLL olgusuna ait periferik kan örneklerinde NOTCH1 gen kopya sayısı artışlarını FISH yöntemi ile incelemeyi ve KLL’nin klinik heterojenitesinde NOTCH1 amplifikasyonunun etkisini araştırmayı amaçladık. Çalışmaya dahil edilen 130 KLL vakasının 4’ünde FISH çalışması başarısızlıkla tamamlanmış olup, geriye kalan 126 olgunun hiçbirinde NOTCH1 gen kopya sayısı değişikliği tespit edilmemiştir. Çalışmamız sonucunda KLL’nin klinik heterojenitesinde NOTCH1 gen amplifikasyonlarının bir etkisi olmadığı sonucuna varılmıştır. Ancak olgu grubumuzun büyük kısmının, iyi prognostik etkiye sahip sitogenetik belirteçlere sahip olması sebebiyle, kötü klinik seyre sahip, daha fazla sayıda KLL vakalarında NOTCH1 gen kopya sayısının araştırılması gerekmektedir.
- 8 December 2023
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (1) , 104-109
Open AccessKLL Olgularında NOTCH1 Gen Amplifikasyonu
Kronik lenfositik lösemi (KLL) ileri yaş hastalarda en sık gözlenen lösemi türü olup, hem klinik hem de genetik açıdan oldukça heterojen bir hastalıktır. Kronik lenfositik lösemi de tekrarlayan kromozom anomalilerinin prognostik önemleri uzun yıllardır bilinmekte olup, gen mutasyonlarının da klinik önemleri açığa kavuşmaya başlamıştır. NOTCH1 gen mutasyonları KLL’de en sık mutasyon gözlenen gen olup, tedavi direnci ve Richter Sendromuna dönüşüm ile ilişkilendirilmektedir. Son yıllarda yapılan çalışmalarda NOTCH1 gen amplifikasyonları çeşitli kanser tiplerinde raporlanmıştır. Bizim daha önce izole delesyon 13q saptanan KLL vakaları ile yaptığımız bir çalışmada NOTCH1 gen dizisini içeren kopya sayısı artışları mikroarray yöntemi ile saptanmıştır ancak klinik bulgular ile ilişkilendirilmemiştir. Biz de bu çalışmamızda çeşitli kromozomal anomalilere sahip ve daha fazla KLL olgusuna ait periferik kan örneklerinde NOTCH1 gen kopya sayısı artışlarını FISH yöntemi ile incelemeyi ve KLL’nin klinik heterojenitesinde NOTCH1 amplifikasyonunun etkisini araştırmayı amaçladık. Çalışmaya dahil edilen 130 KLL vakasının 4’ünde FISH çalışması başarısızlıkla tamamlanmış olup, geriye kalan 126 olgunun hiçbirinde NOTCH1 gen kopya sayısı değişikliği tespit edilmemiştir. Çalışmamız sonucunda KLL’nin klinik heterojenitesinde NOTCH1 gen amplifikasyonlarının bir etkisi olmadığı sonucuna varılmıştır. Ancak olgu grubumuzun büyük kısmının, iyi prognostik etkiye sahip sitogenetik belirteçlere sahip olması sebebiyle, kötü klinik seyre sahip, daha fazla sayıda KLL vakalarında NOTCH1 gen kopya sayısının araştırılması gerekmektedir.
- Open Access
- 1 October 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (10) , 00
ERCC8 related Cockayne syndrome type-1: A rare entity diagnosed in a Turkish boy
Cockayne syndrome (CS, OMIM #216400 and OMIM #133540) is a rare, progressive, multisystemic disorder that results in premature aging and cachectic dwarfism. It is an autosomal recessive disorder with a prevalence of 2-2.5 per million. Pathogenic variants detected in the ERCC excision repair 6 (ERCC6) and ERCC excision repair 8 (ERCC8) genes are responsible for molecular pathogenesis. In this case report, an 11-year-old boy with severe microcephaly, growth retardation, loss of subcutaneous fat tissue, neuromotor developmental delay, bilateral cataracts, and facial dysmorphism but without dermal photosensitivity, who had a novel missense variant in trans configuration with a nonsense variant is presented.
- 1 October 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (10) , 00
Open AccessERCC8 related Cockayne syndrome type-1: A rare entity diagnosed in a Turkish boy
Cockayne syndrome (CS, OMIM #216400 and OMIM #133540) is a rare, progressive, multisystemic disorder that results in premature aging and cachectic dwarfism. It is an autosomal recessive disorder with a prevalence of 2-2.5 per million. Pathogenic variants detected in the ERCC excision repair 6 (ERCC6) and ERCC excision repair 8 (ERCC8) genes are responsible for molecular pathogenesis. In this case report, an 11-year-old boy with severe microcephaly, growth retardation, loss of subcutaneous fat tissue, neuromotor developmental delay, bilateral cataracts, and facial dysmorphism but without dermal photosensitivity, who had a novel missense variant in trans configuration with a nonsense variant is presented.
- Open Access
- 30 November 2022
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 39 (4) , 237-244
The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)
Objective: Chronic myeloid leukemia (CML) is a clonal hematologic disorder characterized by t(9;22) translocation, in which cytogenetic aberrations can occur in Ph(+) and (-) clones. These aberrations develop due to clonal evolution as well as treatment and they have prognostic significance. They are grouped as major and minor route anomalies in terms of their effects on prognostic parameters, such as treatment response, overall survival (OS), disease stage, complete cytogenetic response (CCyR), and major molecular response (MMR). It is stated that major route anomalies have unfavorable prognostic effects compared to minor route anomalies. We aimed to investigate the frequency and prognostic effects of cytogenetic anomalies detected in Ph(+) and (-) clones.Materials and Methods: In this study, we retrospectively analyzed the cytogenetic results of 450 patients diagnosed with CML between 2005 and 2020.Results: We detected cytogenetic aberrations in Ph-positive and negative clones in 41 of 450 patients. The most common anomalies were trisomy 8 (+8), additional Ph chromosome (+Ph), and loss of chromosome Y. Rarely, aneuploidy of the Y chromosome, dup (22), +11, and +6 were seen in CML patients. We observed that these identified aberrations negatively affected MMR and CCyR, and generally resulted in changing imatinib treatment for second-generation tyrosine kinase activity inhibitors. Our results are compatible with the literature.Conclusion: We suggest that cytogenetic aberrations detected in Ph(+) and (-) clones should be a warning sign in terms of treatment and require close observation. The use of cytogenetic methods for the identification of these anomalies is also important.
- 30 November 2022
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 39 (4) , 237-244
Open AccessThe Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)
Objective: Chronic myeloid leukemia (CML) is a clonal hematologic disorder characterized by t(9;22) translocation, in which cytogenetic aberrations can occur in Ph(+) and (-) clones. These aberrations develop due to clonal evolution as well as treatment and they have prognostic significance. They are grouped as major and minor route anomalies in terms of their effects on prognostic parameters, such as treatment response, overall survival (OS), disease stage, complete cytogenetic response (CCyR), and major molecular response (MMR). It is stated that major route anomalies have unfavorable prognostic effects compared to minor route anomalies. We aimed to investigate the frequency and prognostic effects of cytogenetic anomalies detected in Ph(+) and (-) clones.Materials and Methods: In this study, we retrospectively analyzed the cytogenetic results of 450 patients diagnosed with CML between 2005 and 2020.Results: We detected cytogenetic aberrations in Ph-positive and negative clones in 41 of 450 patients. The most common anomalies were trisomy 8 (+8), additional Ph chromosome (+Ph), and loss of chromosome Y. Rarely, aneuploidy of the Y chromosome, dup (22), +11, and +6 were seen in CML patients. We observed that these identified aberrations negatively affected MMR and CCyR, and generally resulted in changing imatinib treatment for second-generation tyrosine kinase activity inhibitors. Our results are compatible with the literature.Conclusion: We suggest that cytogenetic aberrations detected in Ph(+) and (-) clones should be a warning sign in terms of treatment and require close observation. The use of cytogenetic methods for the identification of these anomalies is also important.
- 1 November 2021
- Published by Elsevier in Cancer Genetics
- Vol. 258-259, 7-9
A pediatric BAL case with double Ph chromosomes and trisomy 5
- 1 November 2021
- Published by Elsevier in Cancer Genetics
- Vol. 258-259, 7-9
A pediatric BAL case with double Ph chromosomes and trisomy 5